世界の治療抵抗性うつ病治療市場は、2021年に約15億2,000万米ドルと評価され、予測期間の2022年から2029年には9.0％を超える健全な成長率で成長すると予想されています。治療抵抗性うつ病（TRD）は、治療過程において少なくとも2種類の抗うつ薬の不適切な反応に起因する様々な大うつ病性障害（MDD）です。炎症系の活性化、神経伝達物質の機能不全、異常な神経活動、憂鬱な臨床的特徴、双極性、およびより高い外傷性負荷は、この障害に関連するいくつかの状態です。経口投与と比較して他の投与経路への人気の高まり、医薬品開発プロジェクトの増加、および医療費の増加は、世界中で市場の需要を推進している主な要因です。
この気分障害の有病率の上昇は、市場の成長に貢献している重要な要因です。TRD は、十分な期間（通常は6週間）にわたって 2 回の抗うつ薬の投与に反応しなかった場合に発生します。 この医学的疾患の有病率が上昇した結果、治療抵抗性うつ病の治療に対する需要が高まっています。Springer社の報告によると、2021年8月、世界中で3億人以上の人が重大なうつ病性障害に苦しんでおり、その3分の1以上が治療抵抗性のうつ病であるとのことです。したがって、疾病負担の増大が市場成長の触媒となっています。さらに、研究開発活動への投資の増加や、主要な市場関係者によるイニシアチブの増加が、予測期間中に様々な有利な機会を提示しています。しかし、この気分障害患者の診断と管理のためのガイドラインにおける限られた治療手段と明確性の欠如が、2022年か2029年の予測期間を通じて市場の成長を制限しています。
治療抵抗性うつ病の世界市場の調査対象地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。北アメリカは、ガイドラインや医薬品の承認数の増加、研究開発への多額の投資、市場関係者の関心の高まりにより、収益面で市場を支配しています。一方、アジア太平洋地域は、治療抵抗性うつ病に苦しむ患者数の増加や、気分障害の治療に関連する市場認知度の向上などの要因により、予測期間中に最も高いCAGRで成長すると予想されています。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Treatment-resistant Depression Treatment Market, by Region, 2019-2029 (USD Billion)
1.2.2. Treatment-resistant Depression Treatment Market, by Drug Type, 2019-2029 (USD Billion)
1.2.3. Treatment-resistant Depression Treatment Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Treatment-resistant Depression Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Treatment-resistant Depression Treatment Market Dynamics
3.1. Treatment-resistant Depression Treatment Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rise in the prevalence of treatment-resistant depression
3.1.1.2. Increasing drug development projects
3.1.2. Market Challenges
3.1.2.1. Limited therapeutic measure
3.1.2.2. Lack of clarity in guidelines for diagnosis and management of this mood disorder patients
3.1.3. Market Opportunities
3.1.3.1. Rising investment in research and development activities
3.1.3.2. Increasing initiatives by the key market players
Chapter 4. Global Treatment-resistant Depression Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Treatment-resistant Depression Treatment Market, by Drug Type
6.1. Market Snapshot
6.2. Global Treatment-resistant Depression Treatment Market by Drug Type, Performance - Potential Analysis
6.3. Global Treatment-resistant Depression Treatment Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
6.4. Treatment-resistant Depression Treatment Market, Sub Segment Analysis
6.4.1. NMDA
6.4.2. Antidepressants
6.4.3. Antipsychotics
6.4.4. Others
Chapter 7. Global Treatment-resistant Depression Treatment Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Treatment-resistant Depression Treatment Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Treatment-resistant Depression Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
7.4. Treatment-resistant Depression Treatment Market, Sub Segment Analysis
7.4.1. Hospital Pharmacies
7.4.2. Drug Stores & Retail Pharmacies
7.4.3. Online Pharmacies
Chapter 8. Global Treatment-resistant Depression Treatment Market, Regional Analysis
8.1. Treatment-resistant Depression Treatment Market, Regional Market Snapshot
8.2. North America Treatment-resistant Depression Treatment Market
8.2.1. U.S. Treatment-resistant Depression Treatment Market
8.2.1.1. Drug Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Treatment-resistant Depression Treatment Market
8.3. Europe Treatment-resistant Depression Treatment Market Snapshot
8.3.1. U.K. Treatment-resistant Depression Treatment Market
8.3.2. Germany Treatment-resistant Depression Treatment Market
8.3.3. France Treatment-resistant Depression Treatment Market
8.3.4. Spain Treatment-resistant Depression Treatment Market
8.3.5. Italy Treatment-resistant Depression Treatment Market
8.3.6. Rest of Europe Treatment-resistant Depression Treatment Market
8.4. Asia-Pacific Treatment-resistant Depression Treatment Market Snapshot
8.4.1. China Treatment-resistant Depression Treatment Market
8.4.2. India Treatment-resistant Depression Treatment Market
8.4.3. Japan Treatment-resistant Depression Treatment Market
8.4.4. Australia Treatment-resistant Depression Treatment Market
8.4.5. South Korea Treatment-resistant Depression Treatment Market
8.4.6. Rest of Asia Pacific Treatment-resistant Depression Treatment Market
8.5. Latin America Treatment-resistant Depression Treatment Market Snapshot
8.5.1. Brazil Treatment-resistant Depression Treatment Market
8.5.2. Mexico Treatment-resistant Depression Treatment Market
8.5.3. Rest of Latin America Treatment-resistant Depression Treatment Market
8.6. Rest of The World Treatment-resistant Depression Treatment Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Eli Lilly and Company
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. GlaxoSmithKline Plc
9.2.3. Pfizer Inc.
9.2.4. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
9.2.5. AbbVie Inc.
9.2.6. AstraZeneca Plc
9.2.7. H. Lundbeck A/S
9.2.8. Sandoz International GmbH (Novartis AG)
9.2.9. Par Pharmaceutical (Endo International plc)
9.2.10. Otsuka Pharmaceutical Co., Ltd. (Otsuka Holdings Co., Ltd.)
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
List of Tables
TABLE 1. Global Treatment-resistant Depression Treatment Market, report scope
TABLE 2. Global Treatment-resistant Depression Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Treatment-resistant Depression Treatment Market estimates & forecasts by Drug Type 2019-2029 (USD Billion)
TABLE 4. Global Treatment-resistant Depression Treatment Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 5. Global Treatment-resistant Depression Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Treatment-resistant Depression Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Treatment-resistant Depression Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Treatment-resistant Depression Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Treatment-resistant Depression Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Treatment-resistant Depression Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Treatment-resistant Depression Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Treatment-resistant Depression Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Treatment-resistant Depression Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Treatment-resistant Depression Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Treatment-resistant Depression Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Treatment-resistant Depression Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Treatment-resistant Depression Treatment Market
TABLE 70. List of primary sources, used in the study of global Treatment-resistant Depression Treatment Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Treatment-resistant Depression Treatment Market, research methodology
FIG 2. Global Treatment-resistant Depression Treatment Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Treatment-resistant Depression Treatment Market, key trends 2021
FIG 5. Global Treatment-resistant Depression Treatment Market, growth prospects 2022-2029
FIG 6. Global Treatment-resistant Depression Treatment Market, porters 5 force model
FIG 7. Global Treatment-resistant Depression Treatment Market, pest analysis
FIG 8. Global Treatment-resistant Depression Treatment Market, value chain analysis
FIG 9. Global Treatment-resistant Depression Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Treatment-resistant Depression Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Treatment-resistant Depression Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Treatment-resistant Depression Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Treatment-resistant Depression Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Treatment-resistant Depression Treatment Market, regional snapshot 2019 & 2029
FIG 15. North America Treatment-resistant Depression Treatment Market 2019 & 2029 (USD Billion)
FIG 16. Europe Treatment-resistant Depression Treatment Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Treatment-resistant Depression Treatment Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Treatment-resistant Depression Treatment Market 2019 & 2029 (USD Billion)
FIG 19. Global Treatment-resistant Depression Treatment Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
